PHARMACOKINETICS AND SAFETY/TOLERABILITY OF KL1333, A NOVEL AGENT FOR PRIMARY MITOCHONDRIAL DISORDERS IN HEALTHY MALE SUBJECTS.E. Yang, H. Yoo,M. Ban,K. Huh,Y. Kim, I. -J. Jang, S. Yoon, K. -S. YuCLINICAL PHARMACOLOGY & THERAPEUTICS（2019）引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
